Company Directory - Sensei Biotherapeutics, Inc.
Company Details - Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc.
WebsiteSensei Biotherapeutics, Inc. is a biopharmaceutical company focused on expanding its dose for a treatment in resistant tumors.
CCI Score
CCI Score: Sensei Biotherapeutics, Inc.
-29.73
0.02%
Latest Event
Corporate Governance Investigations Launched Against Sensei Biotherapeutics
Newman Ferrara LLP has initiated investigations on behalf of Sensei Biotherapeutics' shareholders, examining allegations that certain officers and directors breached their fiduciary duties by engaging in self-dealing, approving transactions harmful to the company, and failing to provide adequate oversight of business practices.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
ACCOMPLICE
Sensei Biotherapeutics, Inc. is currently rated as an Accomplice.
Latest Events
- DEC122022
Newman Ferrara LLP has initiated investigations on behalf of Sensei Biotherapeutics' shareholders, examining allegations that certain officers and directors breached their fiduciary duties by engaging in self-dealing, approving transactions harmful to the company, and failing to provide adequate oversight of business practices.
-60
Business Practices and Ethical Responsibility
March 28
The investigation centers on alleged unethical business practices, including self-dealing and harmful transactions that undermine fiduciary responsibilities. These actions point to significant governance issues within the company, reflecting a disregard for ethical standards in business practices.
- DEC122022
Newman Ferrara LLP announced investigations on behalf of shareholders into whether officers and directors of Sensei Biotherapeutics, Inc. breached fiduciary duties by engaging in self-dealing, approving harmful transactions, and failing to provide sufficient oversight.
-60
Business Practices and Ethical Responsibility
March 28
The investigation points to possible breaches of fiduciary duties and failures in corporate governance. These actions reflect unethical business practices that can harm shareholder interests and undermine accountability, which aligns negatively with anti-fascist and progressive standards.
- MAR092022
On March 9, 2022, Sensei Biotherapeutics, Inc. announced the appointment of William (Bill) Ringo, MBA, as Chair of its Board of Directors. With over 40 years of experience in the pharmaceutical and biotechnology industries and former executive roles at both Pfizer and Eli Lilly, Ringo is expected to provide strong leadership and enhance the company's governance practices as it advances its next-generation immunotherapy programs.
+10
Public and Political Behavior
March 28
The appointment of a seasoned leader like William Ringo supports transparent and responsible governance. Strong leadership and accountability are key in safeguarding against authoritarian practices, and his extensive experience in life sciences may steer the company toward ethical engagement in the public arena.
+5
Business Practices and Ethical Responsibility
March 28
This board appointment is a positive signal regarding the company’s commitment to sound business practices and ethical responsibility. Improved governance can promote transparency and accountability, which are critical in ensuring that corporate actions do not inadvertently support authoritarian or undemocratic agendas.
Alternatives
San Carlos, United States
-24.95
Cambridge, USA
-43.03
Corporation
0.00
Corporation
0.00
Corporation
-38.49
Thousand Oaks, USA
13.63
Somerset, United States
1.18
Cambridge, United States
0.27
Mainz, Germany
-6.57
Menlo Park, United States
-49.80
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 541715
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 621511
- Medical Laboratories